PELO

PELO (Pelota) is a ribosome-rescue and translational quality-control factor that, partnered with Hbs1, recognizes and dissociates stalled 80S ribosomes to clear aberrant mRNAs and nascent proteins (PMID:24722736). Through this surveillance activity the Pelo-Hbs1 complex silences transposable elements at the translational level in the germline, independently of piRNA biogenesis (PMID:26124316), and shapes upstream-ORF handling: it promotes proper termination at uORFs in the ATF4 5' leader to enable downstream ATF4 reinitiation, a mechanism conserved from Drosophila to human cells (PMID:41279977). The functional importance of this rescue pathway is underscored by a synthetic-lethal relationship in which PELO depletion in SKIc (superkiller complex)-deficient cancer cells triggers the unfolded protein response, indicating that PELO and the SKIc pathway redundantly resolve stalled ribosomes and aberrant transcripts (PMID:39910293). Beyond ribosome rescue, PELO acts as a catalytic, non-structural assembly factor for cytosolic NLR inflammasomes, binding NLR proteins and activating their ATPase activity to drive correct stepwise assembly of the flagellin-initiated NLRC4 complex (PMID:36948192). PELO additionally participates in growth and signaling control as a protein interactor — it binds active HER2/EGFR to attenuate PI3K/AKT signaling and limit migration and metastasis (PMID:23435426), forms a complex with PLK1 and Smad4 to facilitate Smad4 ubiquitination and degradation (PMID:35437307), and interacts with MYC to upregulate KLF10 during erythroid differentiation (PMID:39206622).

1. 2014 Medium

   Established PELO's core biochemical role: resolving stalled ribosomes, answering whether Pelota acts as a general translation factor or a targeted rescue factor for aberrant translation.

   Evidence Forward genetic screen and ribosome sedimentation in Drosophila pelo mutants, with viral capsid synthesis readout

   PMID:24722736

   Open questions at the time

   • Does not define the structural basis of 80S recognition
   • Mammalian ortholog activity inferred, not directly tested here
2. 2013 Medium

   Extended PELO beyond ribosome rescue by showing it physically engages activated receptor tyrosine kinases to dampen downstream signaling, raising the question of how a rescue factor influences oncogenic signaling.

   Evidence Proteomic identification of HER2 binders, co-IP, migration/invasion and in vivo metastasis assays with knockdown

   PMID:23435426

   Open questions at the time

   • Mechanism of p85-PI3K displacement not resolved
   • Single lab; reciprocal validation limited
3. 2015 Medium

   Connected the Pelo-Hbs1 complex to germline transposon control, showing the rescue machinery silences TEs translationally rather than through piRNA biogenesis.

   Evidence Drosophila genetic loss-of-function, epistasis with RpS30a overexpression, and mammalian PELO rescue

   PMID:26124316

   Open questions at the time

   • How TE mRNAs are selected as substrates is unknown
   • Direct biochemical link between TE mRNA stalling and silencing not shown
4. 2018 Medium

   Showed pelo is a host factor for arboviral replication and a target of antiviral symbiont-mediated regulation, framing PELO as a node where translational surveillance intersects viral fitness.

   Evidence RNAi silencing in Aedes aegypti with viral titer, subcellular localization imaging, miRNA profiling under Wolbachia infection

   PMID:29641562

   Open questions at the time

   • miR-2940-5p regulation of pelo correlative, not demonstrated mechanistically
   • Mechanism linking PELO to virion production undefined
5. 2022 Medium

   Defined a scaffolding role in targeted protein degradation, showing PELO bridges PLK1 and Smad4 to drive Smad4 ubiquitination, distinct from its ribosomal function.

   Evidence Reciprocal co-IP, domain mapping, ubiquitination assays, and in vivo prostate cancer assays with a blocking peptide

   PMID:35437307

   Open questions at the time

   • E3 ligase responsible for Smad4 ubiquitination not identified
   • Whether this role depends on ribosome-rescue activity unknown
6. 2023 High

   Revealed a catalytic, non-structural function for PELO in innate immunity: activating NLR ATPase activity to template stepwise inflammasome assembly, expanding its enzymatic repertoire beyond ribosome dissociation.

   Evidence Co-IP, ATPase activity assays, stoichiometric analysis, and NLRC4 reconstitution with loss-of-function studies

   PMID:36948192

   Open questions at the time

   • Structural mechanism of ATPase activation unresolved
   • Relationship between inflammasome role and ribosome-rescue activity unclear
7. 2024 Medium

   Linked PELO to lineage-specific transcriptional control by showing it cooperates with MYC to regulate KLF10 and modulate erythroid differentiation and proliferation.

   Evidence RNAi knockdown, PELO-MYC co-IP, KLF10/erythroid gene expression analysis, benzidine staining, and cell cycle analysis in K562 cells

   PMID:39206622

   Open questions at the time

   • Whether PELO directly affects MYC activity or is recruited to chromatin unknown
   • Single cell-line context
8. 2024 Medium

   Demonstrated that the Pelo-Hbs1 complex restrains viral tubule assembly via Hsp70 suppression, and that viruses promote PELO ubiquitinated degradation to enable paternal transmission, defining PELO as a regulated antiviral checkpoint.

   Evidence Co-IP (Pns11-Pelo), localization imaging, ubiquitination and Hsp70 activity assays, competition binding, and RNAi in an insect system

   PMID:39122673

   Open questions at the time

   • Identity of the activated E3 ligase not fully defined
   • Conservation of the sperm-surface role beyond insects unknown
9. 2025 High

   Established a clinically actionable synthetic-lethal dependency, showing PELO loss kills SKIc-deficient cancer cells through UPR induction, confirming functional redundancy between PELO and SKIc in clearing aberrant translation.

   Evidence Genome-wide CRISPR knockout screening (DepMap) with genetic validation and UPR assays across two cancer molecular subtypes

   PMID:39910293

   Open questions at the time

   • Precise substrate overlap between PELO and SKIc not enumerated
   • Therapeutic window not characterized
10. 2025 Medium

    Defined a mechanism by which Pelo-Hbs1 governs ATF4 expression, showing proper uORF termination is required for downstream reinitiation, connecting ribosome rescue to stress-responsive gene control.

    Evidence Drosophila genetics with ERG assay, ATF4-rescue epistasis, human cell knockdown, and ATF4 uORF translation reporters (preprint)

    PMID:41279977

    Open questions at the time

    • Preprint; not yet peer-reviewed
    • Whether ATF4 regulation accounts for the UPR phenotype in SKIc-deficient cells not directly tested

• How PELO's single biochemical activity (ribosome/ATPase engagement) is partitioned across its many roles — ribosome rescue, inflammasome assembly, receptor signaling, and targeted protein degradation — remains unresolved.
• No unifying structural model across functions
• Substrate-selection rules for each context undefined
• Whether non-ribosomal roles require Hbs1 partnership unknown